USANA Health Sciences disclosed that Jim Brown stepped down as CEO on January 7, 2026, transitioning to a strategic advisor role, with compensation of $825,000 and a $1.5 million severance package. Kevin Guest assumed the CEO role with an annual salary of $850,000 and potential equity awards valued at $1.7 million, effective February 10, 2026.